<DOC>
	<DOCNO>NCT00994955</DOCNO>
	<brief_summary>Selective Retina Therapy ( SRT ) effective safe laser treatment clinically significant diabetic macular edema target retinal pigment epithelium spar neurosensory retina .</brief_summary>
	<brief_title>Selective Retina Therapy ( SRT ) Clinically Significant Diabetic Macular Edema</brief_title>
	<detailed_description>Abstract : OBJECTIVE : To evaluate effectivity safety Selective Retina Therapy ( SRT ) diabetic macular edema ( DME ) . DESIGN : Prospective two-center interventional uncontrolled case series . PARTICIPANTS : 39 eye 39 patient previously untreated non-ischemic DME . INTERVENTION : Focal laser treatment SRT-Laser selectively affect retinal pigment epithelium spar photoreceptor layer . The pulse energy individually adjust achieve angiographically visible funduscopically invisible effect . Optoacoustic measurement perform detect individual threshold RPE damage laser treatment correlate funduscopy fundus fluorescein angiography ( FFA ) indocyanine green angiography . Follow-up 3 6 month post treatment include best-corrected ETDRS visual acuity ( BCVA ) , FFA , fundus photography , retinal thickness measure optical coherence tomography ( OCT ) . MAIN OUTCOME MEASURES : Change BCVA , change retinal thickness , presence hard exudate leakage FFA , specificity sensitivity optoacoustic measurement . RESULTS : Mean BCVA improve 43.7 letter ( standard deviation , SD=9.1 ) baseline 46.1 letter ( SD=10.5 ) 6 month follow-up ( p=0.02 ) . BCVA improve ( &gt; 5 letter ) remain stable ( +/- 5 letter ) 84 % eye . 13 % eye improve ≥ 10 letter 16 % eye lose 5 letter . There severe loss vision ( loss ≥ 15 letter ) . Overall , mean central retinal thickness , hard exsudates leakage FFA change significantly ( p &gt; 0.05 ) improvement BCVA correlate reduction hard exsudates central retinal thickness . Specificity sensitivity detect angiographic visible threshold RPE damage optoacoustic measurement 86 % 70 % , respectively . No adverse effect pain noted treatment . CONCLUSION : SRT effective safe treatment DME functional anatomical improvement stabilization patient . Optoacoustic measurement suitable detect individual threshold RPE damage .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<criteria>Minimum age 18 year presence clinically significant DME accord criterion ETDRS study Ischemic diabetic macular edema , significant medium opacity compromise interpretation fluorescein angiography fundus photography , previous intraocular surgery , previous macular laser treatment , retinal ocular disease , know allergic hypersensitivity fluorescein , indocyanine green , iodine . General exclusion criterion include pregnancy breastfeed significant medical condition renal failure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>SRT</keyword>
	<keyword>laser</keyword>
	<keyword>diabetic macular edema</keyword>
	<keyword>diabetes</keyword>
	<keyword>Clinically significant diabetic macular edema</keyword>
</DOC>